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Background: An endogenous dopaminergic (DA) tone acting on D3 receptors has been shown to inhibit
tuberoinfundibular (TI) DA neuron activity and stimulate prolactin (PRL) surge in the afternoon of estrogen-primed
ovariectomized (OVX+E2) rats. Whether D2 receptor (D2R) is also involved in the regulation of TIDA and PRL rhythms
was determined in this study.
Results: Intracerebroventricular (icv) injection of PHNO, a D2R agonist, in the morning inhibited TIDA and midbrain DA
neurons’ activities, and stimulated PRL secretion. The effects of PHNO were significantly reversed by co-administration
of raclopride, a D2R antagonist. A single injection of raclopride at 1200 h significantly reversed the lowered TIDA neuron
activity and the increased serum PRL level at 1500 h. Dopamine D2R mRNA expression in medial basal hypothalamus
(MBH) exhibited a diurnal rhythm, i.e., low in the morning and high in the afternoon, which was opposite to that of TIDA
neuron activity. The D2R rhythm was abolished in OVX+E2 rats kept under constant lighting but not in OVX rats with
regular lighting exposures. Pretreatment with an antisense oligodeoxynucleotides (AODN, 10 μg/3 μl/day, icv) against
D2R mRNA for 2 days significantly reduced D2R mRNAs in central DA neurons, and reversed both lowered TIDA neuron
activity and increased serum PRL level in the afternoon on day 3. A diurnal rhythm of D2R mRNA expression was also
observed in midbrain DA neurons and the rhythm was significantly knocked down by the AODN pretreatment.
Conclusions: We conclude that a diurnal change of D2R mRNA expression in MBH may underlie the diurnal rhythms of
TIDA neuron activity and PRL secretion in OVX+E2 rats.
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Dopamine (DA) is a well-established neurohormone that
is synthesized by tuberoinfundibular dopaminergic (TIDA)
neurons in hypothalamic dorsal medial arcuate nucleus
(dmARN) and released from the median eminence (ME).
It is then delivered to anterior pituitary by hypothalamo-
hypophysial portal vessels and acts as a prolactin (PRL)-
inhibiting hormone [1,2].* Correspondence: slliang@mail.cgu.edu.tw
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unless otherwise stated.Intracerebroventricular (icv) injection of DA inhibits
basal TIDA neuron activity in estrogen-primed ovariec-
tomized (OVX+E2) rats [3]. Single-unit recording of
dmARN neurons in brain slices obtained from OVX+E2
rats reveals that DA inhibits the firing rates of 63-74%
dmARN neurons recorded [4-7], and the inhibitory
effect is mimicked by selective D2 and D3 receptor (D2R
and D3R) agonists [5]. The percentage of DA-inhibited
dmARN neurons is significantly reduced (to 39-44%) in
brain slices obtained from OVX+E2 rats pretreated with
antisense oligodeoxynucleotides (AODN) against D2R or
D3R mRNA for 2 days [6]. Combined treatment of both
AODNs reduces the percentage even further (to 18%).td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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neurons exhibit a diurnal change similar to the rhythm
observed in TIDA neuron activity as determined by
neurochemical methods [7]. All the above findings indi-
cate that TIDA neurons possess D2-like autoreceptors
that may mediate the feedback control of their own
activities.
The diurnal rhythm of TIDA neurons, i.e., high in the
morning and low in the afternoon, is essential for the
estrogen-induced PRL afternoon surge [8,9]. We recently
reported that DA acting on D3R inhibits basal TIDA
neuron activity, and an endogenous DA tone acting on
D3R may be involved in the diurnal changes of TIDA
neuron activities and PRL secretion in OVX+E2 rats
[10]. Whether D2R is involved was determined in this
study.
It has been shown that both mouse striatal D3R
mRNA level [11] and D2/D3R proteins [12] exhibit diur-
nal rhythms, which may correlate with motor functions.
There is no report, however, on D2R mRNA level in
medial basal hypothalamus (MBH) where TIDA neurons
reside. Thus, we determined the diurnal changes of
MBH D2R mRNA expression in this study. The D2R
mRNAs in midbrain DA neurons were also measured
for comparison.
PHNO and raclopride, selective D2R agonist and an-
tagonist respectively, and AODN against D2R mRNA
were used in this study. TIDA neuron activity was deter-
mined by measuring DA and its metabolite DOPAC in
the ME, where TIDA neurons terminate. For compari-
son, the activities of nigrostriatal (NS) and mesolimbic
(ML) DA neurons were also determined. The amounts
of D2R mRNA in MBH, substantia nigra (SN) and ven-
tral tegmental area (VTA) were determined by quantita-
tive reverse transcription-polymerase chain reaction
(QRT-PCR). The results clearly show that D2R may play
a significant role in regulating diurnal rhythms of TIDA
neuron activity and PRL secretion.
Methods
Animal sources and treatments
Adult female Sprague–Dawley rats (6- to 8-week-old)
weighing between 220 and 250 g were purchased from
National Yang-Ming University Animal Center (Taipei,
Taiwan, ROC) and BioLASCO Taiwan Co., Ltd (Taipei,
Taiwan, ROC). All animals were housed in a light (lights on
between 06:00 and 20:00 h)- and temperature (23 ± 1°C)-
controlled room with free access to tap water and rat
chow except otherwise notice. All rats used in the ex-
periments were surgically OVX one week before they
were implanted subcutaneously each with a capsule
(silicone tubing, A-M systems, Everett, WA, USA; id,
1.57 mm; od, 3.18 mm; active length, 20 mm) containing
17β-estradiol (E2; 150 μg/ml corn oil; Sigma-Aldrich,St. Louis, MO, USA) except otherwise notice. Plasma
E2 levels of implanted animals are equivalent to proes-
trous levels as previously reported [13]. Each rat also
received implantation of a single icv cannula (23-gauge
stainless steel) in the right lateral cerebroventricle using
a stereotaxic instrument (DKI 900; David Kopf Instru-
ments, Tujunga, CA, USA) at the same time when the
E2 capsule was implanted. Ether or isoflurane were used
as anesthetics for ovariectomy, and equithesin (2 ml/kg
BW, ip) or sodium pentobarbital (50 mg/kg BW, ip)
were used in stereotaxic surgery. All experiments were
performed one week after the implantations.
For icv injections of specific D2 agonist, antagonist and
AODN, a 30-gauge needle connected to a microsyringe
(10 μl) with PE-10 tubing was inserted into the pre-
implanted cannula in each conscious, free moving rat. All
chemicals and vehicles were slowly injected (3 μl/2 min)
into the right lateral cerebroventricle and the animals were
decapitated at specific times afterwards without anesthesia.
The handlings and surgical procedures of animals were
in accordance with the protocols approved by the Insti-
tutional Animal Care and Use committee of Chang
Gung University.
Experimental designs and sample collections
In the first study, both time- and dose-dependent effects
of PHNO were determined in the morning around
1000 h. Groups of rats were sacrificed at 15, 30, 60 or
120 min following the injection of PHNO (0.1 μg, icv).
Rats in the control group received injections of artificial
cerebrospinal fluid (aCSF) and were decapitated at spe-
cific time points afterwards. They were pooled as one
control group since no significant difference was ob-
served. In the dose-dependent study, groups of rats re-
ceived various doses of PHNO (0.001-0.1 μg, icv) and
they were sacrificed at 30 min after the injection. One
group of rats received combined injection of PHNO
(0.1 μg) and raclopride (0.1 μg), a D2R antagonist.
In the second study, a group of rats received injections
of raclopride (10 μg/3 μl, icv) around 1200 h on the ex-
perimentation day and they were sacrificed around
1500 h on the same day. Rats in the control groups re-
ceived vehicle injections and were sacrificed either in the
morning or afternoon on the same day.
In the third study, the D2R mRNA expressions in the
morning and afternoon and the responses to constant
light and absence of E2 exposure were determined. Rats
were OVX on day 1 and divided into three groups with
different treatments on day 7; the first group of rats was
implanted with the E2 and raised under regular light–
dark cycle (OVX+E2, LD), the second group of rats was
implanted with the E2 and raised under constant light
(OVX+E2, LL), the third group of rats was without E2
implantation and raised under regular light–dark cycle
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and afternoon on day 14.
In the fourth study, OVX+E2 rats were divided into
three groups; each received daily icv injections of aCSF,
AODN or random AODN against D2R mRNA (10 μg/
3 μl) for 2 days. On day 3, each group was further divided
into two subgroups: one was sacrificed in the morning
and the other in the afternoon.
After sacrifice, the rat’s brain was quickly removed
from the skull and frozen on dry ice. Thick (600 μm)
coronal brain sections were prepared with a cryostat and
thaw mounted onto glass slides. ME, MBH, SN, VTA,
dorsal lateral striatum (dlST) and nucleus accumbens
(NA) were removed using a modified micropunch tech-
nique [14]. Briefly, the tissues were punched using a
stainless steel needle from one or two frozen slices that
are 2.2-1.0 mm anterior to bregma for punching dlST
and NA, 2.0-3.2 mm posterior to bregma for punching
ME and MBH, and 4.8-6.0 mm posterior to bregma for
punching VTA and SN [15].
For measurement of their monoamine contents, the
punched brain tissues of ME, dlST and NA from each
rat were individually stored in 40 μl of 0.15 M sodium
phosphate buffer containing 0.65 mM sodium octanesul-
phonate, 0.5 mM EDTA, and 12% methanol, with its pH
adjusted to 2.6 using phosphoric acid, and kept at −20°C
until assayed by high-performance liquid chromatog-
raphy (HPLC) plus electrochemical detection. For quan-
titative analysis of D2 mRNA level, the punched brain
tissues of MBH, VTA and SN from each rat were placed
individually in eppendorf vials and stored at −80°C until
assayed by QRT-PCR. The trunk blood of each rat was
individually collected right after decapitation, and the
serum was obtained after centrifugation of the coagu-
lated blood and stored at −20°C until assayed for its PRL
content by radioimmunoassay (RIA).
QRT-PCR
The punched brain tissues from two to three animals of
the same treatment group were pooled together for RNA
extractions using the RNeasy lipid tissue kit (QIAGEN,
Hilden, Germany). The cDNA was then synthesized from
mRNA using the RevertAid™ First Strand cDNA Synthesis
kit (ThermoFisher Scientific, Rockford, IL, USA). Quanti-
tative PCR reactions were carried out using the Maxima
SYBR Green/ROX qPCR master mix (ThermoFisher
Scientific, Rockford, IL, USA) in a PCR machine (7500
Fast Real-Time PCR system, Applied Biosystem, Carlsbad,
CA, USA). Relative quantification of D2R mRNA was ob-
tained via the comparative CT method, and the relative
amounts of the targets were normalized to their own en-
dogenous control GAPDH. The primers used for amplifi-
cation were as follows: GAPDH (BC059110): (forward) 5′-
acagcaacagggtggtggac-3′ and (reverse) 5′-tttgagggtgcagcgaactt-3′; D2R (X56065.1): 5′-gtcctctacagcgccttcac-3′ and
(reverse) 5′-atgaggtctggcctgcatag- 3′. PCR cycle condi-
tions were as follows: 15 s at 95°C, 60 s at 60°C for
45 cycles. The assays were performed at least twice for
all samples.
Resources of chemicals and preparations
PHNO (a gift from Merck, Sharp and Dohme, Whitehouse
Station, NJ, USA) and raclopride (RBI, Natick, MA, USA)
were dissolved in distilled water. The D2 AODN was a 19-
mer (5′-AGG-ACA-GGT-TCA-GTG-GAT-C-3′) comple-
mentary to codons 2–8 (nucleotides 4–22) of the D2R
mRNA. The random sequence for D2 AODN (5′-AGA-
ACG-GCA-CTT-AGT-GGG-T-3′), was used as control.
All sequences were adopted from previous studies [6,16]
and were synthesized by a local company (Watson Bio-
technology Co. LTD. Taipei, Taiwan) or IDT (Integrated
DNA Technologies, Inc. Coralville, IA, USA). The ODN
were phosphorothioate-modified to increase the resistance
from degradation by endogenous nucleases [17,18], and
they were dissolved in aCSF for icv injections. The com-
position of aCSF is as follows (in mM): NaCl 125.1, KCl
3.8, KH2PO4 1.2, MgSO4 1.3, CaCl2 2.4, NaHCO3 26, and
dextrose 10.
Chemical assays and statistical analysis
Dopamine and its metabolite 3,4-dihydroxyphenylacetic
acid (DOPAC) levels in the ME, dlST and NA were de-
termined by HPLC with electrochemical detection as
previously described [3,8,9,19]. Protein contents in
punched brain tissues used for HPLC were measured by
the Lowry method [20]. Activities of TIDA, NSDA and
MLDA neurons were estimated using the index of
DOPAC/DA ratio. Materials used in PRL RIA were kindly
provided by Dr. A.F. Parlow of the National Hormone and
Pituitary Programme of NIDDK, USA.
Statistical analyses were conducted using either two-way
or one-way ANOVA for testing significant differences
among time points and/or treatments. One-way ANOVA
followed by the Student-Newman-Keuls’ multiple range
test were performed for all groups. Differences were con-
sidered significant at p < 0.05 or p < 0.01.
Results
Effects of PHNO, a D2 receptor agonist, on basal TIDA,
NSDA and MLDA neuron activities and serum PRL levels
in OVX+E2 rats
In the time-dependent study, icv injection of 0.1 μg
PHNO significantly decreased DOPAC/DA ratios in ME,
dlST and NA (p < 0.05 for ME and NA; p < 0.01 for ST;
Figures 1 and 2), and increased serum PRL levels (p < 0.05;
Figure 1) at 30, but not 15, 60, or 120 min. In the
dose–response study, injection of 0.1, but not 0.001 or
0.01 μg PHNO significantly decreased DOPAC/DA
Figure 1 Effects of a D2 receptor agonist, PHNO (0.1 μg/3 μl, icv),
on ME DOPAC/DA ratio (upper) and serum PRL (lower) level in
OVX+E2 rats in the morning. Data are expressed as mean ± SEM
(n = 5–7 rats). *, p < 0.05 compared with respective control groups.
Figure 2 Effects of PHNO (0.1 μg/3 μl, icv) on dlST (upper) and
NA (lower) DOPAC/DA ratios in OVX+E2 rats in the morning.
Data are expressed as mean ± SEM (n = 5–7 rats). *, p < 0.05, **, p < 0.01
compared with respective control groups.
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p < 0.01 for dlST; Figures 3 and 4) and increased serum
PRL level (p < 0.05; Figure 3) at 30 min. Co-administration
with raclopride (0.1 μg) significantly reversed the in-
hibitory effects of PHNO on DOPAC/DA ratios in ME
(p < 0.05; Figure 3), dlST and NA (p < 0.05; Figure 4),
and the stimulatory effect of PHNO on serum PRL level
(p < 0.01; Figure 3).
Involvement of D2R in diurnal changes of TIDA neuron
activity and PRL secretion in OVX+E2 rats
The diurnal changes of TIDA neuron activity and serum
PRL level were observed in aCSF-injected rats in which
ME DOPAC/DA ratio in the afternoon was significantly
lower than that in the morning (p < 0.05; Figure 5) and
serum PRL level in the afternoon was significantly higher
than that in the morning (p < 0.01; Figure 5). Injection of
raclopride (10 μg/3 μl, icv) at 1200 h significantly reversed
the lowered ME DOPAC/DA ratio (p < 0.05; Figure 5),and prevented the serum PRL level at 1500 h (p < 0.01;
Figure 5). Nevertheless, serum PRL level at 1500 h was
still significantly higher than that in the morning (p < 0.05;
Figure 5).
Light- but not E2-dependent diurnal expression of D2R
mRNA in MBH
The D2R mRNA ratio in MBH of OVX+E2 rats exhibited
a prominent diurnal change, i.e., low in the morning and
high in the afternoon (p < 0.01; Figure 6). This rhythm
persisted in OVX animals (p < 0.01; Figure 6) but was
abolished in OVX+E2 animals kept under constant light
exposure for 7 days (p < 0.05; Figure 6).
Effects of AODN and random AODN against D2R mRNA
on expressions of D2R mRNA in MBH, SN and VTA, and on
TIDA neuron activities and serum PRL levels in both
morning and afternoon of OVX+E2 rats
The diurnal changes in the expression of MBH D2R
mRNA (higher in the afternoon), TIDA neuron activity
(lower in the afternoon using ME DOPAC/DA as the
Figure 3 Effects of PHNO (0.001, 0.01, 0.1 μg/3 μl/rat) and
co-administration of PHNO (0.1 μg) with a D2 receptor antagonist,
raclopride (0.1 μg), on ME DOPAC/DA ratio (upper) and serum PRL
(lower) level in OVX+E2 rats in the morning. Data are expressed as
mean ± SEM (n = 5–7 rats). *, p < 0.05, compared with respective
control groups. #, p < 0.05; ##, p < 0.01 compared with the PHNO
(0.1 μg)-injected group.
Figure 4 Effects of PHNO (0.001, 0.01, 0.1 μg/3 μl/rat) and
co-administration of PHNO (0.1 μg) with raclopride (0.1 μg) on
dlST (upper) and NA (lower) DOPAC/DA ratios in OVX+E2 rats
in the morning. Data are expressed as mean ± SEM (n = 5–7 rats).
*, p < 0.05; **, p < 0.01 compared with respective control groups.
#, p < 0.05 compared with the PHNO (0.1 μg)-injected groups.
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were confirmed in aCSF-treated control rats (Figure 7).
Pretreatment with AODN against D2R mRNA signifi-
cantly lowered MBH D2R mRNA and serum PRL level
(p < 0.01; Figure 7), and increased ME DOPAC/DA ratio
(p < 0.05; Figure 7) in the afternoon, while it had no sig-
nificant effects in the morning. Pretreatment with ran-
dom AODN against D2R mRNA had no significant
effect on any of the three variables compared with those
in aCSF-treated control (Figure 7).
D2R mRNAs in NS and VTA also exhibited a diurnal
rhythm with their afternoon levels significantly lower
than those in the morning (p < 0.01; Table 1). Pretreat-
ment with AODN significantly lowered morning levels
of D2R mRNA in NS and VTA (p < 0.05 and 0.01 respect-
ively; Table 1) plus afternoon level in VTA (p < 0.01;
Table 1), and disrupted the diurnal rhythm in both re-
gions. Pretreatment with the random AODN had no sig-
nificant effects on D2R mRNA ratios in NS and VTA
(Table 1).Discussion
We recently reported that an endogenous DA tone act-
ing on DA D3Rs may be involved in diurnal changes of
TIDA neuron activity and PRL secretion in OVX+E2 rats
[10]. We further demonstrated in this study that D2Rs
were also involved. Moreover, we found that the expres-
sion of D2R mRNA in the MBH exhibited a diurnal
change that persisted in OVX animals but was abolished
in OVX+E2 animals kept under constant lighting expos-
ure, so was the response of TIDA neuron activity. To
our knowledge, this is the first report showing that a di-
urnal change in the expression of D2R mRNA exists in
MBH neurons.
PHNO has been characterized as a highly specific D2
receptor agonist which binds primarily to the high-
affinity state of D2Rs rather than D3Rs in the striatum
[21] and exhibits a 67-fold selectivity for D2Rs versus
D1Rs [22,23]. The findings that PHNO inhibited the ac-
tivities of all three central DA neurons tested and its in-
hibitory effects were blocked by co-administration of
Figure 5 Effects of a single injection of raclopride (10 μg/3 μl,
icv) at 1200 h on ME DOPAC/DA ratio (upper) and serum PRL
(lower) level at 1500 h in OVX+E2 rats. Data are expressed as
mean ± SEM (n = 5–7 rats). *, p < 0.05; ** p < 0.01, compared with the
control groups in the morning; #, p < 0.05; ##, p < 0.01 compared
with respective control groups in the afternoon.
Figure 6 Morning and afternoon D2R mRNA ratios in MBH and
their responses to constant light and E2 exposures (A) and a
schematic drawing of the coronal section of the rat brain (B)
showing the punched area of MBH [grey circles, [15]]. A: Data
are expressed as mean ± SEM (n = 10–14 rats in each treatment
group). **, p < 0.01, compared with the control groups in the
morning. #, p < 0.05 compared with the control groups in the
afternoon. B: 3 V: the third ventricle; dmARN: dorsal medial arcuate
nucleus; ME: median eminence.
Liang et al. Journal of Biomedical Science 2014, 21:37 Page 6 of 9
http://www.jbiomedsci.com/content/21/1/37raclopride further strengthen the notion that D2 autore-
ceptors are involved in the control of central DA neu-
rons. Raclopride not only blocked the effect of PHNO
on TIDA neuron activity, it further lowered serum PRL
to below control levels, indicating that not only D2Rs
but other D2R-like receptors may be involved. Due to
technical limitations, the time-dependent changes in
TIDA neuron activity can only be determined using dif-
ferent groups of rats sacrificed at different time points,
but not in individual rats. It is possible that the effect of
PHNO was maximal at 30 min and the effects at earlier
and later time points may be obscured in group averages.
We used OVX rats with estrogen replacement because
the diurnal changes of TIDA neuron activity and after-
noon PRL surge are gender specific and induced byestrogen [8]. We have repeatedly shown that the diurnal
change in TIDA neuron activity is prerequisite for the
estrogen-induced PRL afternoon surge [8,9,24]. Disrupt-
ing the TIDA rhythm invariably blunts the PRL surge.
The previous [10] and present studies using D3R and
D2R antagonists to disrupt the TIDA rhythm further
confirm the notion. It appears that an endogenous DA
tone acting on D2-like receptors during a critical period
of time (from 1200 to 1400 h) is responsible for the low-
ered TIDA neuron activity in the afternoon.
Although raclopride treatment completely reversed the
afternoon decrease of TIDA neuron activity and signifi-
cantly blunted the PRL surge, it did not block the surge
completely, i.e., serum PRL level in the afternoon was
still higher than that in the morning. This indicates that
factor(s) other than withdrawal of DA inhibition
Figure 7 Effects of antisense oligodeoxynucleotides (AODN) or
random AODN (10 μg/3 μl, icv) pretreatment against D2R
mRNA for 2 days on MBH D2R mRNA ratios (upper; arbitrary unit),
ME DOPAC/DA (middle) and serum PRL (lower) levels both in the
morning and afternoon in OVX+E2 rats. Data are expressed as
mean ± SEM (n = 5–7 rats for DOPAC/DA ratio and PRL level; n = 12–14
rats for MBH D2R mRNA in each treatment group). *, p < 0.05; ** p < 0.01,
compared with respective control groups in the morning; #, p < 0.05;
##, p < 0.01 compared with respective control groups in the afternoon.
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creased inhibition by DA (PRL-inhibiting hormone) plus
increased stimulation by a putative PRL-releasing hor-
mone are required for a full-blown PRL surge [25-27].
The present finding further substantiates the notion.
That the mRNA of D2Rs in MBH exhibited a diurnal
rhythm and was disrupted by constant light exposure
are novel findings. It appears that when TIDA neuron
activity was high, the expression of D2R mRNA was low,
and vice versa. Moreover, the findings that both D2R
mRNA and TIDA diurnal rhythms are sensitive to con-
stant light exposure but persist in OVX rats are consist-
ent with the criteria of true circadian rhythms [8,28].
Pretreatment with an AODN against D2 receptor mRNA
not only reversed the increased expression of D2 recep-
tor mRNA in the afternoon, but also prevented the diur-
nal changes of TIDA neuron activity and PRL secretion.
This finding indicates that the diurnal change in the ex-
pression of D2R mRNA may underlie the changes of
TIDA neuron activity and in turn the PRL surge, al-
though the exact mechanism needs further work.
This study raised another interesting issue on the ori-
gin of dopamine acting on TIDA neurons. Dopamine
may arise from recurrent collaterals of TIDA neurons or
from other hypothalamic DA neurons including
periventricular-hypophysial (PH) and tuberohypophysial
(TH) DA neurons [29]. It has been shown that rhythm-
related genes are present not only in suprachiasmatic
nucleus (SCN) and ARN [30], but also in hypothalamic
DA neurons, including TIDA, PHDA and THDA neurons
[31], indicating that these neurons may generate their ownTable 1 Dopamine D2 receptor mRNA ratios in SN and
VTA of OVX+E2 rats as determined by QRT-PCR
aCSF D2 AODN D2 random AODN
SN AM 1.00 ± 0.01 0.76 ± 0.06# 1.33 ± 0.13
PM 0.78 ± 0.02** 0.86 ± 0.03 0.99 ± 0.05*
VTA AM 1.02 ± 0.02 0.42 ± 0.02## 1.38 ± 0.19
PM 0.77 ± 0.01** 0.46 ± 0.06# 0.53 ± 0.08**
Data are expressed as mean ± SEM (n = 8-12 rats in each group). *, p < 0.05;
**, p < 0.01, compared with respective control groups in the morning; #, p < 0.05;
##, p < 0.01 compared with respective aCSF-treated groups at the same time point.
Groups of OVX+E2 rats received icv injections of aCSF, antisense
oligodeoxynucleotides (AODN, 10 μg/3 μl), or random AODN against D2
receptor mRNA for 2 days were sacrificed either in the morning or afternoon.
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neurons in vitro also reveals a diurnal rhythm of their fir-
ing rates [7]. On the other hand, it is well-established that
SCN is the master biological clock that coordinates most
circadian rhythms observed in mammals and bilateral le-
sions of the SCN eliminate both TIDA diurnal rhythm
and the estrogen-induced PRL surge [9], indicating an
entraining signal originated from SCN can affect directly
or indirectly on TIDA neurons.
Circadian changes of midbrain DA neurons’ activities
in rats have been reported with their levels higher during
dark hours when the animals exhibit nocturnal motor
activities [28,32]. Recent studies have shown that striatal
D2/D3R proteins and D3R mRNA levels in mouse also
exhibit diurnal rhythms [11,12]. Our findings that D2R
mRNAs in SN and VTA exhibited a morning high, after-
noon low rhythm are in agreement with the changes of
D3R mRNA levels in mouse striatum [12]. That the D2R
mRNAs in SN and VTA were significantly lowered by
pretreatment of AODN against D2R mRNA further con-
firms the knockdown effects of AODN.
Conclusions
The present study demonstrates that D2Rs are involved
in the inhibitory actions of exogenous and endogenous
dopamine on TIDA neuron activity. Moreover, a diurnal
change of D2R mRNA expression in the MBH may be
involved in the diurnal rhythms of TIDA neuron activity
and PRL secretion in OVX+E2 rats.
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